These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6652 related articles for article (PubMed ID: 3205595)
21. The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroid and skin. Albert DM; Chang MA; Lamping K; Weiter J; Sober A Ophthalmology; 1985 Dec; 92(12):1728-34. PubMed ID: 4088626 [TBL] [Abstract][Full Text] [Related]
22. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact. Sørensen FB; Kristensen IB; Grymer F; Jakobsen A Am J Dermatopathol; 1991 Feb; 13(1):11-9. PubMed ID: 2003643 [TBL] [Abstract][Full Text] [Related]
23. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study. von Roenn JH; Kheir SM; Wolter JM; Coon JS Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035 [TBL] [Abstract][Full Text] [Related]
24. Mutations of the BRAF gene in benign and malignant melanocytic lesions. Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620 [TBL] [Abstract][Full Text] [Related]
25. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275 [TBL] [Abstract][Full Text] [Related]
26. Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation. Korabiowska M; Brinck U; Ruschenburg I; Schlott T; Droese M; Stachura J Pol J Pathol; 1999; 50(1):17-21. PubMed ID: 10412270 [TBL] [Abstract][Full Text] [Related]
27. Comparison of DNA ploidy status and DNA ploidy-related parameters in malignant melanoma tissue microarrays and full sections. Korabiowska M; Cordon-Cardo C; Buschmann N; Stachura J; Fischer G; Brinck U Hum Pathol; 2004 Jul; 35(7):887-91. PubMed ID: 15257554 [TBL] [Abstract][Full Text] [Related]
28. Nuclear DNA profiles in primary melanomas and their metastases. Rode J; Williams RA; Charlton IG; Dhillon AP; Moss E Cancer; 1991 May; 67(9):2333-6. PubMed ID: 2013040 [TBL] [Abstract][Full Text] [Related]
29. BRAF and NRAS mutations in melanoma and melanocytic nevi. Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322 [TBL] [Abstract][Full Text] [Related]
31. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements. Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744 [TBL] [Abstract][Full Text] [Related]
32. Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation. Bassoli S; Pellegrini C; Longo C; Di Nardo L; Farnetani F; Cesinaro AM; Pellacani G; Fargnoli MC Melanoma Res; 2018 Apr; 28(2):166-169. PubMed ID: 29485552 [No Abstract] [Full Text] [Related]
33. DNA-index and stereological estimation of nuclear volume in primary and metastatic malignant melanomas: a comparative study with analysis of heterogeneity. Sørensen FB; Kristensen IB; Grymer F; Jakobsen A APMIS; 1990 Jan; 98(1):61-70. PubMed ID: 2302343 [TBL] [Abstract][Full Text] [Related]
34. Examination of DNA-ploidy in melanocytic nevi cells using video-imaging cytometry. Skowronek J; Filipiak K; Karaś Z; Krenz RM; Włodarczyk H Pol J Pathol; 1997; 48(1):37-41. PubMed ID: 9200959 [TBL] [Abstract][Full Text] [Related]
35. Classifying melanocytic tumors based on DNA copy number changes. Bastian BC; Olshen AB; LeBoit PE; Pinkel D Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the nuclear deoxyribonucleic acid content and nuclear morphometry in 71 primary cutaneous melanomas. Renard N; Goldschmidt D; Decaestecker C; Lorea P; Berthe JV; Verraes S; Ghanem G; Salmon I; Kiss R Dermatology; 1997; 194(4):318-24. PubMed ID: 9252750 [TBL] [Abstract][Full Text] [Related]
37. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma. Chi HI; Ishibashi Y; Shima A; Mihara I; Otsuka F J Invest Dermatol; 1990 Aug; 95(2):154-7. PubMed ID: 2380576 [TBL] [Abstract][Full Text] [Related]
38. Melanoma in situ (MIS) adjacent to an invasive nodular melanoma ("SSM/NM") and its metastases--DNA-cytophotometry, mitotic index, and anisokaryosis. Schmiegelow P; Oppermann T; Nüssgen A; Schroiff R; Jänner M; Breitbart EW Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):213-21. PubMed ID: 3113063 [TBL] [Abstract][Full Text] [Related]
39. Flow and video-imaging cytometry--usefulness of DNA ploidy measurements in diagnosis of malignant melanoma. Skowronek J; Karaś Z; Krenz RM; Warchoł JB Adv Exp Med Biol; 2001; 495():435-8. PubMed ID: 11774606 [No Abstract] [Full Text] [Related]
40. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi. Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]